vs

Side-by-side financial comparison of AGENUS INC (AGEN) and Nano Dimension Ltd. (NNDM). Click either name above to swap in a different company.

Nano Dimension Ltd. is the larger business by last-quarter revenue ($57.8M vs $34.2M, roughly 1.7× AGENUS INC). AGENUS INC runs the higher net margin — -31.0% vs -171.1%, a 140.0% gap on every dollar of revenue.

Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.

Nano Dimension Ltd. is a leading provider of additively manufactured electronics solutions and 3D printing technologies. It designs high-precision 3D printers, related materials, and software for producing printed circuit boards, microelectronics components, and multi-layer electronic devices, serving aerospace, defense, medical, automotive, and industrial electronics segments across global markets.

AGEN vs NNDM — Head-to-Head

Bigger by revenue
NNDM
NNDM
1.7× larger
NNDM
$57.8M
$34.2M
AGEN
Higher net margin
AGEN
AGEN
140.0% more per $
AGEN
-31.0%
-171.1%
NNDM

Income Statement — Q4 FY2025 vs Q4 FY2024

Metric
AGEN
AGEN
NNDM
NNDM
Revenue
$34.2M
$57.8M
Net Profit
$-10.6M
$-98.8M
Gross Margin
43.1%
Operating Margin
42.1%
-155.1%
Net Margin
-31.0%
-171.1%
Revenue YoY
27.5%
Net Profit YoY
77.3%
EPS (diluted)
$0.09
$-0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AGEN
AGEN
NNDM
NNDM
Q4 25
$34.2M
Q3 25
$30.2M
Q2 25
$25.7M
Q1 25
$24.1M
Q4 24
$26.8M
$57.8M
Q3 24
$25.1M
Q2 24
$23.5M
$28.4M
Q1 24
$28.0M
Net Profit
AGEN
AGEN
NNDM
NNDM
Q4 25
$-10.6M
Q3 25
$63.9M
Q2 25
$-30.0M
Q1 25
$-26.4M
Q4 24
$-46.8M
$-98.8M
Q3 24
$-67.2M
Q2 24
$-54.8M
$-79.2M
Q1 24
$-63.5M
Gross Margin
AGEN
AGEN
NNDM
NNDM
Q4 25
Q3 25
97.9%
Q2 25
99.1%
Q1 25
99.4%
Q4 24
99.6%
43.1%
Q3 24
99.4%
Q2 24
99.5%
45.8%
Q1 24
99.6%
Operating Margin
AGEN
AGEN
NNDM
NNDM
Q4 25
42.1%
Q3 25
-15.0%
Q2 25
-65.0%
Q1 25
-55.3%
Q4 24
-96.5%
-155.1%
Q3 24
-125.5%
Q2 24
-128.4%
Q1 24
-117.4%
Net Margin
AGEN
AGEN
NNDM
NNDM
Q4 25
-31.0%
Q3 25
211.4%
Q2 25
-116.8%
Q1 25
-109.6%
Q4 24
-174.4%
-171.1%
Q3 24
-267.7%
Q2 24
-233.1%
-279.4%
Q1 24
-226.6%
EPS (diluted)
AGEN
AGEN
NNDM
NNDM
Q4 25
$0.09
Q3 25
$1.94
Q2 25
$-1.00
Q1 25
$-1.03
Q4 24
$-1.95
$-0.45
Q3 24
$-3.08
Q2 24
$-2.52
$-0.35
Q1 24
$-3.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AGEN
AGEN
NNDM
NNDM
Cash + ST InvestmentsLiquidity on hand
$3.0M
$317.2M
Total DebtLower is stronger
$44.7M
Stockholders' EquityBook value
$-271.1M
$860.0M
Total Assets
$226.8M
$902.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AGEN
AGEN
NNDM
NNDM
Q4 25
$3.0M
Q3 25
$3.5M
Q2 25
$9.5M
Q1 25
$18.5M
Q4 24
$40.4M
$317.2M
Q3 24
$44.8M
Q2 24
$93.7M
$231.8M
Q1 24
$52.9M
Total Debt
AGEN
AGEN
NNDM
NNDM
Q4 25
$44.7M
Q3 25
$34.2M
Q2 25
$33.9M
Q1 25
$33.6M
Q4 24
$33.2M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AGEN
AGEN
NNDM
NNDM
Q4 25
$-271.1M
Q3 25
$-274.1M
Q2 25
$-354.6M
Q1 25
$-341.8M
Q4 24
$-326.4M
$860.0M
Q3 24
$-292.3M
Q2 24
$-241.3M
$870.3M
Q1 24
$-201.4M
Total Assets
AGEN
AGEN
NNDM
NNDM
Q4 25
$226.8M
Q3 25
$233.9M
Q2 25
$185.2M
Q1 25
$200.2M
Q4 24
$226.3M
$902.5M
Q3 24
$238.5M
Q2 24
$292.4M
$911.0M
Q1 24
$256.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AGEN
AGEN
NNDM
NNDM
Operating Cash FlowLast quarter
$-16.6M
$-18.9M
Free Cash FlowOCF − Capex
$-21.1M
FCF MarginFCF / Revenue
-36.5%
Capex IntensityCapex / Revenue
0.0%
3.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AGEN
AGEN
NNDM
NNDM
Q4 25
$-16.6M
Q3 25
$-14.7M
Q2 25
$-20.2M
Q1 25
$-25.6M
Q4 24
$-28.7M
$-18.9M
Q3 24
$-53.3M
Q2 24
$-38.2M
$-30.7M
Q1 24
$-38.2M
Free Cash Flow
AGEN
AGEN
NNDM
NNDM
Q4 25
Q3 25
Q2 25
$-20.2M
Q1 25
$-25.6M
Q4 24
$-28.7M
$-21.1M
Q3 24
$-53.3M
Q2 24
$-38.6M
Q1 24
$-38.2M
FCF Margin
AGEN
AGEN
NNDM
NNDM
Q4 25
Q3 25
Q2 25
-78.7%
Q1 25
-106.5%
Q4 24
-107.0%
-36.5%
Q3 24
-212.2%
Q2 24
-164.4%
Q1 24
-136.5%
Capex Intensity
AGEN
AGEN
NNDM
NNDM
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
0.3%
3.8%
Q3 24
0.0%
Q2 24
2.0%
Q1 24
0.1%
Cash Conversion
AGEN
AGEN
NNDM
NNDM
Q4 25
Q3 25
-0.23×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AGEN
AGEN

Non Cash Royalty Revenue$31.1M91%
Other$3.2M9%

NNDM
NNDM

Segment breakdown not available.

Related Comparisons